Peripheral Neuropathy Trial, Recruiting NCT06096675 Sponsor: Wake Forest University Health Sciences Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06096675
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be over 18 years old
  • You have been diagnosed with heart failure that is mild to moderate in severity (meaning you may have some symptoms during activity, but you are not severely limited)
  • You are physically able to exercise
  • You are currently on a stable treatment plan for cardiac amyloidosis (a condition where abnormal proteins build up in the heart), or you are being monitored without treatment
  • You are expected to live for at least 6 months or more
  • You are able to understand and willing to sign a consent form written in English
  • You are willing and able to take part in a cardiac rehabilitation exercise program

Who may not be able to join:

  • You are not able to give informed consent to participate
  • You are unable to commit to attending in-person supervised exercise sessions three times a week (one hour each session) for 12 weeks
  • You have severe heart failure that significantly limits your daily activities even at rest
  • You have a lung condition that requires you to use oxygen at home
  • You have problems with balance or walking, or you have a history of falls
  • In the opinion of the lead doctor running the trial, you have another serious health condition that could affect your ability to complete the trial or affect the accuracy of the results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jai Singh, MD, Wake Forest University Health Sciences

Phone: 704-355-4692

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 January 2024
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants that complete at least 75% of prescribed cardiac rehab sessions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov